On 30 May 2016
Marksans Pharma will hold a meeting of the Board of Directors of the Company on 30 May 2016, to consider and approve Audited Financial Results of the Company for the financial year ended 31 March 2016 and to consider recommendation of dividend, if any, for the financial year ended 31 March 2016.Powered by Capital Market - Live News
